FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...